Label: DR. RECKEWEG R51 THYREOSAN COMBINATION PRODUCT- belladonna 30x, hekla lava 12x, iodium 30x, lapis albus 12x, lycopus virginicus 12x, natrum muriaticum 30x liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved homeopathic

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Drug Label Information

Updated April 5, 2013

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Active ingredients

    Belladonna 30X, Hekla Lava 12X, Iodium 30X, Lapis albus 12X, Lycopus virginicus 12X, Natrum muriaticum 30X, 1 g each in 10 g. 

  • PURPOSE


    Purpose

    Relieves symptoms associated with hyperthyroidism


  • INDICATIONS & USAGE


    Uses

    For the temporary relief of minor symptoms associated with hyperthyroidism such as:


    • Palpitations
    • Increased appetite
    • Weight loss
    • Oily skin

  • WARNINGS

    Warnings

    Stop use and ask a doctor if symptoms persist, get worse, or if new symptoms occur.

    If pregnant or breastfeeding, ask a health care professional before use.

    Keep out of reach of children.

  • DOSAGE & ADMINISTRATION


    Directions
    Adults 5-10 drops 1-3 times daily in a little water or undiluted or as recommended. 

  • OTHER SAFETY INFORMATION

    Other information

    • Tamper resistant: do not use if safety ring at base of cap is broken.
    • Retain outer carton for full product information.

  • INACTIVE INGREDIENT


    Inactive ingredients

    Ethanol, purified water.



  • QUESTIONS


    Questions?

    Call 1-800-361-7872 or email questions@reckeweg.com
  • PRINCIPAL DISPLAY PANEL


    image of carton label

    NDC# 53346-1351-5

    Dr. Reckeweg R51 Thyreosan

    Homeopathic preparation for the temporary relief of minor symptoms associated with hyperthyroidism such as:

    • Palpitations
    • Increased appetite
    • Weight loss
    • Oily skin

    Manufactured by:

    Dr. Reckeweg Co. GmbH

    D-64625 Bensheim

    Germany

    1.68 fl oz
    (50 ml)

  • INGREDIENTS AND APPEARANCE
    DR. RECKEWEG R51 THYREOSAN  COMBINATION PRODUCT
    belladonna 30x, hekla lava 12x, iodium 30x, lapis albus 12x, lycopus virginicus 12x, natrum muriaticum 30x liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:53346-1351
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ATROPA BELLADONNA (UNII: WQZ3G9PF0H) (ATROPA BELLADONNA - UNII:WQZ3G9PF0H) ATROPA BELLADONNA30 [hp_X]  in 50 mL
    HEKLA LAVA (UNII: C21158IIRK) (HEKLA LAVA - UNII:C21158IIRK) HEKLA LAVA12 [hp_X]  in 50 mL
    IODINE (UNII: 9679TC07X4) (IODINE - UNII:9679TC07X4) IODINE30 [hp_X]  in 50 mL
    CALCIUM HEXAFLUOROSILICATE (UNII: 2NVP93XVQ3) (CALCIUM HEXAFLUOROSILICATE - UNII:2NVP93XVQ3) CALCIUM HEXAFLUOROSILICATE12 [hp_X]  in 50 mL
    LYCOPUS VIRGINICUS (UNII: TWH5125Q6F) (LYCOPUS VIRGINICUS - UNII:TWH5125Q6F) LYCOPUS VIRGINICUS12 [hp_X]  in 50 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698, SODIUM CATION - UNII:LYR4M0NH37) SODIUM CHLORIDE30 [hp_X]  in 50 mL
    Inactive Ingredients
    Ingredient NameStrength
    ALCOHOL (UNII: 3K9958V90M)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:53346-1351-550 mL in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved homeopathic06/01/1986
    Labeler - PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO (318602612)
    Establishment
    NameAddressID/FEIBusiness Operations
    PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO318602612manufacture(53346-1351)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!